What treatments are effective for uveitic macular edema? Drs. Nisha R. Acharya and Douglas A. Jabs of the MUST Research Group join Dr. Edmund Tsui to discuss landmark findings of the Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy (MERIT) trial, from their recent Ophthalmology article, “Intravitreal Therapy for Uveitic Macular Edema—Ranibizumab versus Methotrexate versus the Dexamethasone Implant.”Intravitreal Therapy for Uveitic Macular Edema—Ranibizumab versus Methotrexate versus the Dexamethasone Implant. Acharya, Nisha R. et al. Ophthalmology, Volume 130, Issue 9, 914 - 9
For all episodes, visit www.aao.org/podcasts.
Subscribe
Apple Podcasts
Spotify
Google Podcasts
RSS
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.